Hematological Markers as Predictors of COVID-19 Severity: A Prospective Study from South India
Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction: Coronavirus disease 2019 (COVID-19) demonstrates wide clinical heterogeneity, ranging from mild illness to severe pneumonia, acute respiratory distress syndrome, and multiorgan failure. Early identification of patients at risk of severe disease is essential, particularly in resource-limited settings. Simple hematological and inflammatory markers may aid in early prediction of disease severity. Methods: A prospective observational study was conducted on 100 RT-PCRconfirmed COVID-19 patients admitted between December 2020 and October 2022 at Prathima Institute of Medical Sciences, South India. Patients were categorized as critical or non-critical according to World Health Organization (WHO) severity criteria. Hematological indices and inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), lymphocyte percentage, D-dimer, and interleukin-6 (IL-6), were analyzed and compared between the two groups. Results: The median NLR was significantly higher in critical patients compared to non-critical patients (6.35 vs 4.00; p Conclusion: Elevated NLR, lymphopenia, and increased IL-6 and D-dimer levels are reliable predictors of COVID-19 severity and may assist in early risk stratification and clinical decision-making.
Source: PERSPECTIVES IN MEDICAL RESEARCH
Authors: Kanakam Varun, Shaik Riyaz Parveen, Asma Anjum, Audi Thanmayi Naidu, BVN Padmaja
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7160445565
FWCI:
Cites:
Cited by:
Related to: